Animal-study meta-analysis finds behavioral effects, but mixed cognition results
Effects of cannabidiol on anxiety- and depressive-like behaviors and cognition: a systematic review and meta-analysis of preclinical studies.
AI Summary
This systematic review and meta-analysis examined 123 animal studies to assess whether cannabidiol (CBD) affects anxiety-like and depressive-like behaviors and cognition. Across the preclinical models, CBD consistently reduced anxiety- and depressive-like behaviors, with moderate effects reported in several behavioral tests. These are animal findings, not evidence of treatment effects in people.
Cognitive outcomes were mixed: CBD improved performance in some memory and discrimination tasks, while effects in spatial-memory tests were small or inconsistent. Results often varied by test type and underlying pathology. The abstract reports possible involvement of serotonergic signaling, the endocannabinoid system, and other biological pathways, but says human clinical evidence remains limited and inconclusive. This abstract-based summary cannot establish whether CBD is effective or safe for anxiety, depression, or cognitive problems in people.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
A lab method measures 17 cannabinoids across five hemp product types
CBD showed limited adaptive-functioning differences versus placebo in boys…
NMR profiling finds THC predominates in Moroccan beldia extracts
Explore More Research
Stay informed about the latest cannabis science.